Elexacaftor, Tezacaftor, / Ivacaftor
Common brands: Trikafta, Pulmozyme, Creon, Albuterol, Walgreens
Top reporter: Vertex Pharmaceuticals Incorporated
Recombinant Human Deoxyribonuclease 1 [EPC]Osmotic Laxative [EPC]Aminoglycoside Antibacterial [EPC]Proton Pump Inhibitor [EPC]Provitamin D2 Compound [EPC]
12,133
Total Reports
6,109
Serious Reports
229
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (1.89%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Elexacaftor, Tezacaftor, / Ivacaftor.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS | 792 | |
| 2 | HEADACHE | 758 | |
| 3 | ANXIETY | 592 | |
| 4 | COUGH | 588 | |
| 5 | RASH | 565 | |
| 6 | PRODUCTIVE COUGH | 523 | |
| 7 | FATIGUE | 518 | |
| 8 | WEIGHT INCREASED | 501 | |
| 9 | CYSTIC FIBROSIS | 488 | |
| 10 | ABDOMINAL PAIN UPPER | 468 | |
| 11 | DEPRESSION | 433 | |
| 12 | HOSPITALISATION | 419 | |
| 13 | PNEUMONIA | 383 | |
| 14 | DIARRHOEA | 381 | |
| 15 | INFECTION | 337 | |
| 16 | MENTAL DISORDER | 329 | |
| 17 | NAUSEA | 322 | |
| 18 | INSOMNIA | 321 | |
| 19 | DYSPNOEA | 305 | |
| 20 | INFLUENZA | 293 | |
| 21 | CONSTIPATION | 271 | |
| 22 | PRODUCT DOSE OMISSION ISSUE | 254 | |
| 23 | NASOPHARYNGITIS | 251 | |
| 24 | ABDOMINAL PAIN | 235 | |
| 25 | DIZZINESS | 230 | |
| 26 | COVID-19 | 228 | |
| 27 | FEELING ABNORMAL | 227 | |
| 28 | OFF LABEL USE | 218 | |
| 29 | HEPATIC ENZYME INCREASED | 211 | |
| 30 | BRAIN FOG | 207 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.